Concise Preparation of a Stable Cyclic Sulfamidate Intermediate in the Synthesis of a Enantiopure Chiral Active Diamine Derivative
暂无分享,去创建一个
[1] J. Coyle,et al. Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia , 2010, Dialogues in clinical neuroscience.
[2] N. Zanatta,et al. Synthesis and characterization of new trifluoromethyl substituted 3‐ethoxycarbonyl‐ and 3‐pyrimidin‐2‐yl)‐(1,2,3)‐oxathiazinane‐S‐oxides , 2008 .
[3] G. Hilmersson,et al. Improved and efficient synthesis of chiral N,P-ligands via cyclic sulfamidates for asymmetric addition of butyllithium to benzaldehyde. , 2007, Organic letters.
[4] R. Depoortère,et al. Neurochemical, Electrophysiological and Pharmacological Profiles of the Selective Inhibitor of the Glycine Transporter-1 SSR504734, a Potential New Type of Antipsychotic , 2005, Neuropsychopharmacology.
[5] J. Lowe. Novel inhibitors of the type 1 transporter for glycine (GlyT1) as antipsychotic agents , 2005 .
[6] R. Peters,et al. Preparation and diastereoselective ortho-metalation of chiral ferrocenyl imidazolines: remarkable influence of LDA as metalation additive. , 2005, Organic letters.
[7] E. Dolence,et al. Use of optically active cyclic diethyl sulfamidate 2-phosphonates as chiral synthons for the synthesis of β-substituted α-amino phosphonates , 2005 .
[8] M. Roje,et al. Partial hydrogenation of substituted pyridines and quinolines: a crucial role of the reaction conditions , 2003 .
[9] Nikolai A. Khanjin,et al. Synthesis of the Spermidine Alkaloids (−)‐(2R,3R)‐ and (−)‐(2R,3S)‐3‐Hydroxycelacinnine: Macrocyclization with Oxirane‐Ring Opening and Inversion via Cyclic Sulfamidates , 2003 .
[10] W. Lubell,et al. Synthesis and reactivity of cyclic sulfamidites and sulfamidates , 2003 .
[11] D. Gray,et al. 1,2-cyclic sulfamidates as versatile precursors to thiomorpholines and piperazines. , 2003, Organic letters.
[12] J. Grierson,et al. New routes to N-alkylated cyclic sulfamidates. , 2002, The Journal of organic chemistry.
[13] T. Tewson,et al. Substitution Reactions of Hindered Cyclic Sulfamidates , 2002 .
[14] M. Pilkington,et al. New carbon-carbon bond forming reactions of cyclic sulfate esters and cyclic sulfamidates , 2002 .
[15] R. Halcomb,et al. Application of serine- and threonine-derived cyclic sulfamidates for the preparation of S-linked glycosyl amino acids in solution- and solid-phase peptide synthesis. , 2002, Journal of the American Chemical Society.
[16] T. Tewson,et al. Fluoroamines via Chiral Cyclic Sulfamidates , 2002 .
[17] W. Lubell,et al. N-(9-(9-Phenylfluorenyl))homoserine-Derived Cyclic Sulfamidates: Novel Chiral Educts for the Synthesis of Enantiopure γ-Substituted α-Amino Acids , 2001 .
[18] R. Halcomb,et al. Synthesis of S-linked glycosyl amino acids in aqueous solution with unprotected carbohydrates. , 2001, Organic letters.
[19] W. Lubell,et al. Scope and limitations in the use of N-(PhF)serine-derived cyclic sulfamidates for amino acid synthesis , 2001 .
[20] W. Lubell,et al. Racemization in the Use of N-(9-(9-Phenylfluorenyl))Serine-Derived Cyclic Sulfamidates in the Synthesis of δ-Keto α-Amino Carboxylates and Prolines , 2000 .
[21] M. Fisher,et al. Improved syntheses of fluorinated tertiary butylamines , 1999 .
[22] D. Horwell,et al. Generation of unnatural α,α-disubstituted amino acid derivatives from cyclic sulfamidates , 1999 .
[23] A. Fernández-Mayoralas,et al. Synthesis of a Thio-Analogue of Lewis X by Regioselective Opening of Cyclic Sulfamidates. , 1998, The Journal of organic chemistry.
[24] Carlos Jaramillo,et al. Use of cyclic sulfamidates derived from D-allosamine in nucleophilic displacements: Scope and limitations , 1997 .
[25] N. Meunier,et al. Synthesis of optically active hydroxy amino acids via 2-O-benzylglyceraldehyde N-[(R)-1-phenylethyl]imine , 1996 .
[26] A. Fernández-Mayoralas,et al. Nucleophilic displacements on a cyclic sulfamidate derived from allosamine: application to the synthesis of thiooligosaccharides , 1996 .
[27] M. Kilbourn,et al. Fluorine for hydroxy substitution in biogenic amines: asymmetric synthesis and biological evaluation of fluorine-18-labeled beta-fluorophenylalkylamines as model systems. , 1995, Journal of medicinal chemistry.
[28] J. Cossy,et al. Formation of optically active 3-hydroxypiperidines , 1995 .
[29] K. Tomioka,et al. Stereo- and regiochemical aspects of the Mitsunobu reaction in synthesis of chiral amino ether ligands for asymmetric reactions , 1994 .
[30] M. Pilkington,et al. Synthesis and stability of the cyclic sulfamidate of N-trityl-L-serine methyl ester , 1993 .
[31] K. E. Mccarthy,et al. Alkylation of the cyclic sulfamate of prolinol. Preparation of optically active 2-alkyl-substituted pyrrolidines , 1992 .
[32] M. Garst,et al. Cyclic sulfamate from N-substituted 2-amino-3-phenyl-1-propanol and its nucleophilic reactions , 1991 .
[33] P. Anderson,et al. Synthesis and pharmacological evaluation of a series of dibenzo[a,d]cycloalkenimines as N-methyl-D-aspartate antagonists. , 1990, Journal of medicinal chemistry.
[34] C. Schofield,et al. Cyclic sulphamidates : new synthetic precursors for β-functionalised α-amino acids , 1990 .
[35] T. Lyle,et al. Fluoride-induced formation and ring opening of cyclic sulfamates from hydroxy triflamides: synthetic and mechanistic studies , 1987 .
[36] P. Dvortsák,et al. Synthesis and antiarrhythmic activity of N-aryl alkylenediamines , 1987 .
[37] R. Fuller,et al. Inhibition of phenylethanolamine N-methyltransferase by benzylamines. 1. Structure-activity relationships. , 1973, Journal of medicinal chemistry.
[38] W. Houlihan,et al. Synthesis and antiinflammatory acitivity of 2-aryl-2-alpha-piperidyl-1,3-dioxanes. , 1969, Journal of medicinal chemistry.
[39] Villani Fj,et al. THE CHEMISTRY OF THE BENZYLPYRIDINES. V. BETA-PHENYL-BETA-PYRIDYL-BETA-HYDROXYPROPIONIC ACIDS AND DERIVATIVES AS ANTISPASMODIC AGENTS. , 1963 .